A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Public ClinicalTrials.gov record NCT03257358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Month, Prospective, Multicenter, Two-cohort, Nonrandomized, Open-label Study in Adult Patients With Relapsing Multiple Sclerosis (RMS), to Investigate Changes in Immune Phenotype Biomarkers After Treatment With 0.5mg Fingolimod [FLUENT]
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study of immune phenotype biomarkers in patients with Relapsing Multiple Sclerosis (RMS) after treatment with 0.5mg fingolimod
Study identification
- NCT ID
- NCT03257358
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 382 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 19, 2017 (Actual)
- Primary completion
- Mar 5, 2019 (Actual)
- Completion
- Jun 28, 2019 (Actual)
- Last update posted
- Oct 7, 2021
2017 – 2019
United States locations
- U.S. sites
- 66
- U.S. states
- 29
- U.S. cities
- 63
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Birmingham | Alabama | 35209 | — |
| Novartis Investigative Site | Cullman | Alabama | 35058 | — |
| Novartis Investigative Site | Tucson | Arizona | 85718 | — |
| Novartis Investigative Site | Berkeley | California | 94705 | — |
| Novartis Investigative Site | Sacramento | California | 95817 | — |
| Novartis Investigative Site | Colorado Springs | Colorado | 80907 | — |
| Novartis Investigative Site | Louisville | Colorado | 80027 | — |
| Novartis Investigative Site | Boca Raton | Florida | 33482 | — |
| Novartis Investigative Site | Boca Raton | Florida | 33487 | — |
| Novartis Investigative Site | Jacksonville | Florida | 32209 | — |
| Novartis Investigative Site | Miami | Florida | 33136 | — |
| Novartis Investigative Site | Ocala | Florida | 34471 | — |
| Novartis Investigative Site | Port Charlotte | Florida | 33952 | — |
| Novartis Investigative Site | Sarasota | Florida | 34243 | — |
| Novartis Investigative Site | Sunrise | Florida | 33351 | — |
| Novartis Investigative Site | Vero Beach | Florida | 32960 | — |
| Novartis Investigative Site | Savannah | Georgia | 31406 | — |
| Novartis Investigative Site | Suwanee | Georgia | 30024 | — |
| Novartis Investigative Site | Flossmoor | Illinois | 60422 | — |
| Novartis Investigative Site | Kansas City | Kansas | 66160 | — |
| Novartis Investigative Site | Louisville | Kentucky | 40202 | — |
| Novartis Investigative Site | Louisville | Kentucky | 40207 | — |
| Novartis Investigative Site | Lutherville | Maryland | 21093 | — |
| Novartis Investigative Site | Foxborough | Massachusetts | 02035 | — |
| Novartis Investigative Site | Lexington | Massachusetts | 02421 | — |
| Novartis Investigative Site | Wellesley | Massachusetts | 02481 | — |
| Novartis Investigative Site | Ann Arbor | Michigan | 48109 | — |
| Novartis Investigative Site | Owosso | Michigan | 48867 | — |
| Novartis Investigative Site | Golden Valley | Minnesota | 55422 | — |
| Novartis Investigative Site | Kansas City | Missouri | 64111 | — |
| Novartis Investigative Site | St Louis | Missouri | 63131 | — |
| Novartis Investigative Site | Las Vegas | Nevada | 89106 | — |
| Novartis Investigative Site | Fair Lawn | New Jersey | 07410 | — |
| Novartis Investigative Site | Livingston | New Jersey | 07039 | — |
| Novartis Investigative Site | Patchogue | New York | 11772 | — |
| Novartis Investigative Site | Plainview | New York | 11803 | — |
| Novartis Investigative Site | Asheville | North Carolina | 28806 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28207 | — |
| Novartis Investigative Site | Mooresville | North Carolina | 28117 | — |
| Novartis Investigative Site | Raleigh | North Carolina | 27607 | — |
| Novartis Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| Novartis Investigative Site | Cleveland | Ohio | 44195 | — |
| Novartis Investigative Site | Dayton | Ohio | 45408 | — |
| Novartis Investigative Site | Toledo | Ohio | 43623 | — |
| Novartis Investigative Site | Westerville | Ohio | 43081 | — |
| Novartis Investigative Site | Oklahoma City | Oklahoma | 73102 | — |
| Novartis Investigative Site | Oklahoma City | Oklahoma | 73104 | — |
| Novartis Investigative Site | Portland | Oregon | 97225 | — |
| Novartis Investigative Site | Philadelphia | Pennsylvania | 19140 | — |
| Novartis Investigative Site | Greer | South Carolina | 29650 | — |
| Novartis Investigative Site | Mt. Pleasant | South Carolina | 29464 | — |
| Novartis Investigative Site | Port Royal | South Carolina | 29935 | — |
| Novartis Investigative Site | Knoxville | Tennessee | 37922 | — |
| Novartis Investigative Site | Nashville | Tennessee | 37215 | — |
| Novartis Investigative Site | Dallas | Texas | 75246 | — |
| Novartis Investigative Site | San Antonio | Texas | 78258 | — |
| Novartis Investigative Site | Falls Church | Virginia | 22043 | — |
| Novartis Investigative Site | Vienna | Virginia | 22182 | — |
| Novartis Investigative Site | Kirkland | Washington | 98034 | — |
| Novartis Investigative Site | Seattle | Washington | 98122 | — |
| Novartis Investigative Site | Spokane | Washington | 99202 | — |
| Novartis Investigative Site | Tacoma | Washington | 98405 | — |
| Novartis Investigative Site | Huntington | West Virginia | 25701 | — |
| Novartis Investigative Site | Green Bay | Wisconsin | 54311 | — |
| Novartis Investigative Site | Milwaukee | Wisconsin | 53215 | — |
| Novartis Investigative Site | Neenah | Wisconsin | 54956 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03257358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 7, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03257358 live on ClinicalTrials.gov.